SLN
Silence Therapeutics
SLN
SLN
65 hedge funds and large institutions have $168M invested in Silence Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
66% less capital invested
Capital invested by funds: $493M → $168M (-$325M)
93% less call options, than puts
Call options by funds: $3K | Put options by funds: $45K
Holders
65
Holding in Top 10
3
Calls
$3K
Puts
$45K
Top Buyers
| 1 | +$6.48M | |
| 2 | +$5.85M | |
| 3 | +$3.44M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.43M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.2M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$18.2M | |
| 3 | -$18.2M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.27M |
| 5 |
DFO
Duquesne Family Office
New York
|
-$7.04M |